Glutamate and Its Receptors as Therapeutic Targets for Migraine

Neurotherapeutics - United States
doi 10.1007/s13311-018-0616-5
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC